PHO92 Antibody

What is PHO92 and what role does it play in cellular processes?

PHO92 is an N6-methyladenosine (m6A) reader protein containing a YTH domain that specifically recognizes m6A-modified mRNA in yeast. Current research indicates that PHO92 is likely the sole m6A reader in Saccharomyces cerevisiae . PHO92 has drawn significant research interest because:

• It plays a crucial role in the onset of meiosis, similar to the m6A methyltransferase Ime4

• It demonstrates dual functionality, promoting both the decay of m6A-modified transcripts and enhancing their translation

• It is recruited co-transcriptionally through direct binding to the transcription elongation complex Paf1C

• It exhibits dynamic nuclear-cytoplasmic localization, suggesting compartment-specific functions

• Its study provides insights into evolutionary conservation of m6A reader functions across species

The relationship between PHO92 and meiosis is particularly noteworthy, as strains expressing PHO92 with mutations in the YTH domain that disrupt m6A binding show delayed meiosis onset compared to control strains .

What methods are recommended for validating PHO92 antibodies?

Rigorous validation of PHO92 antibodies is essential for ensuring experimental reliability. A comprehensive approach should include:

• Genetic controls: Test antibodies on samples from wild-type and pho92Δ strains to confirm specificity

• CRISPR/Cas9 modification: Generate cell lines with PHO92 knockout and compare antibody binding between parental and knockout lines

• Immunoblot analysis: Perform Western blots across different samples, including positive and negative controls

• Epitope mapping: Determine which region of PHO92 the antibody recognizes to ensure suitability for intended applications

• Application-specific validation: Perform targeted validation for immunoprecipitation, immunofluorescence, or other specific uses

A systematic validation approach, as described in current antibody characterization protocols, involves:

• Identifying cell lines with high PHO92 expression through proteomic databases

• Creating knockout models using CRISPR/Cas9

• Testing antibodies by comparing parental and knockout lines

• Validating antibodies across multiple applications (immunoblot, immunoprecipitation, immunofluorescence)

What are the optimal storage and handling conditions for PHO92 antibodies?

Proper storage and handling of PHO92 antibodies are crucial for maintaining their activity and specificity:

• Storage temperature: Store antibody aliquots at -20°C for long-term preservation

• Aliquoting: Divide antibodies into small working aliquots (50-100μL) upon receipt to minimize freeze-thaw cycles, which can severely degrade antibody activity

• Dilution medium: For phospho-specific detection, use BSA instead of milk for diluting antibodies, as milk contains phosphorylated casein that causes high background

• Buffer composition: For long-term storage of diluted antibodies, add sodium azide (0.01-0.1%) to prevent microbial growth

• Working solution stability: When properly stored with sodium azide, diluted antibody solutions can be kept at 4°C for weeks to months, though sensitivity may decrease over time

How can PHO92 antibodies be used to study m6A-dependent RNA regulation?

PHO92 antibodies provide valuable tools for investigating m6A-dependent RNA regulation mechanisms:

• Differential binding analysis: Compare PHO92 binding to RNA targets in wild-type and ime4Δ strains (lacking m6A modifications) using RNA immunoprecipitation followed by sequencing (RIP-seq)

• Integrative analyses: Combine PHO92 CLIP data with m6A mapping (miCLIP) to correlate PHO92 binding sites with m6A-modified positions on target transcripts

• RNA decay measurements: Monitor the stability of m6A-modified transcripts in the presence or absence of PHO92 through transcription inhibition experiments

• Translation efficiency assessment: Investigate how PHO92 affects polysome association of m6A-modified mRNAs

What are the considerations when using PHO92 antibodies in co-immunoprecipitation experiments?

When performing co-immunoprecipitation (co-IP) with PHO92 antibodies, researchers should consider several technical aspects:

• Buffer optimization: Use buffers that preserve native protein interactions while minimizing background

• RNase treatment: Determine whether interactions are RNA-dependent by performing parallel IPs with and without RNase treatment, particularly important for PHO92 which directly binds RNA

• Stringency controls: Include appropriate controls such as IgG-only pulldowns and immunoprecipitations from pho92Δ strains

• Reciprocal co-IPs: Validate interactions by performing reciprocal co-IPs using antibodies against suspected interaction partners (e.g., Paf1C components)

• Subcellular fractionation: Since PHO92 localizes to both nuclear and cytoplasmic compartments, fractionation before IP may help identify compartment-specific interaction partners

For PHO92-Paf1C interaction studies specifically, crosslinking may be necessary to capture the co-transcriptional recruitment of PHO92 to nascent RNA. The search results indicate that PHO92 associates with nascent nuclear RNA in a Paf1C-dependent manner, which requires specialized IP conditions to detect properly .

How can PHO92 antibodies help investigate nuclear-cytoplasmic dynamics?

PHO92 demonstrates dynamic localization between nuclear and cytoplasmic compartments, and antibodies can reveal these patterns:

• Immunofluorescence microscopy: Visualize PHO92 subcellular distribution under different conditions (e.g., vegetative growth vs. meiosis)

• Biochemical fractionation: Perform cellular fractionation followed by immunoblotting to quantitatively assess PHO92 distribution between compartments

• Stimulus-response experiments: Monitor PHO92 localization changes in response to stimuli like nutrient depletion or meiotic induction

• Co-localization studies: Perform dual immunofluorescence with markers of nuclear transcription sites, P-bodies, or stress granules

The search results highlight that PHO92 may have distinct functions in different cellular compartments. In the nucleus, it associates with nascent transcripts through Paf1C, while in the cytoplasm, it promotes both mRNA decay and translation . This dual localization pattern makes PHO92 antibodies valuable tools for investigating compartment-specific functions.

What methodologies are recommended for studying PHO92's interaction with the Paf1C complex?

To investigate the interaction between PHO92 and the Paf1C transcription elongation complex, several methodologies can be employed:

• Chromatin immunoprecipitation (ChIP): Use PHO92 antibodies to determine if PHO92 associates with chromatin at actively transcribed genes through Paf1C

• Sequential ChIP (ChIP-reChIP): Perform sequential immunoprecipitation with antibodies against Paf1C components followed by PHO92 antibodies to identify co-localization regions

• Co-immunoprecipitation: Use PHO92 antibodies to pull down associated proteins and detect Paf1C components

• Deletion mutant analysis: Compare PHO92-Paf1C interactions using antibodies against wild-type PHO92 and domain deletion mutants

The relationship between PHO92 and Paf1C represents an important connection between transcription and post-transcriptional regulation. The search results suggest that Pho92 is recruited co-transcriptionally through direct binding to Paf1C, although the specific functional consequences of this interaction remain under investigation .

How should researchers address troubleshooting and specificity issues with PHO92 antibodies?

When encountering specificity problems with PHO92 antibodies, researchers can implement these troubleshooting strategies:

• Genetic validation: Compare antibody signals between wild-type and pho92Δ samples - a specific antibody should show no signal in the knockout

• Peptide competition: Pre-incubate the antibody with the immunizing peptide - specific signals should be eliminated in peptide-blocked samples

• Alternative antibody comparison: Test multiple antibodies targeting different PHO92 epitopes and compare their patterns

• Optimizing blocking conditions: For detection of potential phosphorylated forms of PHO92, use BSA instead of milk for blocking and antibody dilution

For antibodies targeting potential phosphorylated forms of PHO92, special considerations include using phosphatase inhibitors during sample preparation and avoiding milk-based blockers due to the presence of phosphorylated casein .

What applications are most suitable for PHO92 antibodies in RNA biology research?

PHO92 antibodies serve as versatile tools in RNA biology research, with applications including:

• Western blotting: Detecting PHO92 protein levels in yeast extracts under different conditions (e.g., meiosis induction, stress responses)

• RNA immunoprecipitation (RIP): Identifying mRNAs bound by PHO92, particularly those containing m6A modifications

• Cross-linking immunoprecipitation (CLIP): Precisely mapping PHO92 binding sites on target RNAs at nucleotide resolution

• Chromatin immunoprecipitation (ChIP): Investigating the co-transcriptional recruitment of PHO92 to chromatin via Paf1C

• Immunofluorescence microscopy: Visualizing PHO92 subcellular localization and potential shuttling between nucleus and cytoplasm

The choice of application should be guided by the specific research question. For example, CLIP-seq has proven particularly valuable for identifying m6A-dependent and m6A-independent PHO92 binding sites on RNA. Analysis of Pho92 iCLIP revealed that 16.7% of all detected peaks were reliably reduced in ime4Δ mutants, demonstrating the power of this approach for distinguishing m6A-dependent interactions .

How can PHO92 antibodies be used to investigate its role in meiosis?

Investigating PHO92's role in meiosis requires specialized approaches with antibodies:

• Meiotic time course analysis: Use PHO92 antibodies for Western blotting and immunofluorescence across a meiotic time course to track changes in expression, modification, and localization

• Genetic background comparisons: Compare PHO92 protein levels and localization in wild-type, ime4Δ, and PHO92 YTH domain mutant strains

• Co-immunoprecipitation during meiosis: Use PHO92 antibodies to identify meiosis-specific interaction partners

• RIP-seq during meiosis: Use PHO92 antibodies for RNA immunoprecipitation followed by sequencing to identify meiosis-specific RNA targets

The search results highlight that both PHO92 and IME4 (the m6A methyltransferase) influence meiotic progression, and mutations in PHO92's YTH domain that disrupt m6A binding delay meiosis onset . Specifically, epistasis analysis revealed that single and double mutants of pho92Δ and IME4 catalytically inactive mutants have comparable delays in meiosis onset, suggesting the catalytic function of IME4 and PHO92 function are in the same pathway .

What controls should be included when validating PHO92 antibody specificity?

Comprehensive controls are essential for validating PHO92 antibody specificity:

• Genetic knockout: The gold standard control is comparing wild-type samples with pho92Δ strains

• Domain mutants: Include PHO92 YTH domain mutants to distinguish domain-specific recognition

• Loading controls: Use established housekeeping proteins (e.g., actin, GAPDH) to normalize protein loading

• Cross-reactivity controls: Test the antibody against other YTH domain proteins to assess specificity

• Blocking peptide controls: Pre-absorb antibody with immunizing peptide before use

• Secondary antibody-only controls: Assess background from secondary antibody

The antibody characterization procedure described in search result offers a systematic approach for validation that can be applied to PHO92 antibodies. This includes using CRISPR/Cas9 to generate knockout cell lines, which provides definitive evidence of antibody specificity .

What experimental considerations are important when studying PHO92's dual role in mRNA decay and translation?

PHO92's unique dual functionality in promoting both mRNA decay and translation requires specialized experimental designs:

• Temporal analysis: Use PHO92 antibodies to track protein dynamics during the transition from translation to decay

• Translation inhibitor studies: Compare PHO92-RNA associations with and without translation inhibitors

• Polysome profiling: Fractionate polysomes and detect PHO92 distribution using antibodies to assess ribosome association

• Decay rate measurements: Block transcription and measure the decay rates of m6A-modified versus unmodified transcripts in wild-type and pho92Δ strains

• Compartment-specific analysis: Differentiate between nuclear and cytoplasmic PHO92 functions through fractionation and immunoprecipitation

The search results indicate that PHO92-mediated mRNA decay appears to be contingent on the translation process . Despite the substantial effect on mRNA decay, proteomics and time-course experiments revealed that protein levels of PHO92/m6A targets do not decrease proportionally with their mRNAs in pho92Δ mutants, suggesting that PHO92 also enhances translation efficiency . These findings highlight the complex interplay between translation and decay that can be further investigated using PHO92 antibodies.